X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2018 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare Biocon Ltd with - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

BIOCON LTD vs ALKEM LABORATORIES - Comparison Results

BIOCON LTD    Change

Biocon is India's largest biotechnology company with presence in biopharmaceuticals, custom research and clinical research. It started as an enzymes manufacturer and later evolved into an integrated biopharmaceutical company. The company has two subs... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    BIOCON LTD ALKEM LABORATORIES BIOCON LTD/
ALKEM LABORATORIES
 
P/E (TTM) x 96.0 - - View Chart
P/BV x 7.8 6.7 117.1% View Chart
Dividend Yield % 0.2 0.6 24.4%  

Financials

 BIOCON LTD   ALKEM LABORATORIES
EQUITY SHARE DATA
    BIOCON LTD
Mar-17
ALKEM LABORATORIES
Mar-16
BIOCON LTD/
ALKEM LABORATORIES
5-Yr Chart
Click to enlarge
High Rs1,1621,589 73.1%   
Low Rs4831,232 39.2%   
Sales per share (Unadj.) Rs194.6417.5 46.6%  
Earnings per share (Unadj.) Rs34.456.3 61.1%  
Cash flow per share (Unadj.) Rs48.364.7 74.6%  
Dividends per share (Unadj.) Rs1.0012.70 7.9%  
Dividend yield (eoy) %0.10.9 13.5%  
Book value per share (Unadj.) Rs241.9292.9 82.6%  
Shares outstanding (eoy) m200.00119.57 167.3%   
Bonus/Rights/Conversions ---  
Price / Sales ratio x4.23.4 125.1%   
Avg P/E ratio x23.925.1 95.4%  
P/CF ratio (eoy) x17.021.8 78.1%  
Price / Book Value ratio x3.44.8 70.6%  
Dividend payout %2.922.6 12.9%   
Avg Mkt Cap Rs m164,440168,653 97.5%   
No. of employees `0009.2NA-   
Total wages/salary Rs m7,4709,171 81.4%   
Avg. sales/employee Rs Th4,213.9NM-  
Avg. wages/employee Rs Th809.0NM-  
Avg. net profit/employee Rs Th745.2NM-  
INCOME DATA
Net Sales Rs m38,91149,915 78.0%  
Other income Rs m1,5711,645 95.5%   
Total revenues Rs m40,48251,561 78.5%   
Gross profit Rs m9,7958,482 115.5%  
Depreciation Rs m2,7721,006 275.6%   
Interest Rs m260671 38.8%   
Profit before tax Rs m8,3348,451 98.6%   
Minority Interest Rs m163-114 -143.2%   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m1,6161,606 100.6%   
Profit after tax Rs m6,8816,731 102.2%  
Gross profit margin %25.217.0 148.1%  
Effective tax rate %19.419.0 102.0%   
Net profit margin %17.713.5 131.1%  
BALANCE SHEET DATA
Current assets Rs m40,47727,062 149.6%   
Current liabilities Rs m16,78315,324 109.5%   
Net working cap to sales %60.923.5 258.9%  
Current ratio x2.41.8 136.6%  
Inventory Days Days6067 89.6%  
Debtors Days Days8341 200.7%  
Net fixed assets Rs m45,07312,610 357.5%   
Share capital Rs m1,000239 418.2%   
"Free" reserves Rs m47,37734,490 137.4%   
Net worth Rs m48,37735,027 138.1%   
Long term debt Rs m21,0821,212 1,740.0%   
Total assets Rs m93,94254,387 172.7%  
Interest coverage x33.113.6 243.0%   
Debt to equity ratio x0.40 1,259.8%  
Sales to assets ratio x0.40.9 45.1%   
Return on assets %7.613.6 55.9%  
Return on equity %14.219.2 74.0%  
Return on capital %12.624.9 50.7%  
Exports to sales %012.9 0.0%   
Imports to sales %03.1 0.0%   
Exports (fob) Rs mNA6,461 0.0%   
Imports (cif) Rs mNA1,540 0.0%   
Fx inflow Rs m12,9886,563 197.9%   
Fx outflow Rs m7,8993,012 262.3%   
Net fx Rs m5,0893,552 143.3%   
CASH FLOW
From Operations Rs m6,4007,259 88.2%  
From Investments Rs m-4,9851,864 -267.4%  
From Financial Activity Rs m-1,775-9,273 19.1%  
Net Cashflow Rs m-473-150 315.3%  

Share Holding

Indian Promoters % 40.4 66.9 60.4%  
Foreign collaborators % 20.6 0.0 -  
Indian inst/Mut Fund % 8.4 33.1 25.4%  
FIIs % 10.7 0.0 -  
ADR/GDR % 0.0 0.0 -  
Free float % 19.9 0.0 -  
Shareholders   109,995 68,381 160.9%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare BIOCON LTD With:   DIVIS LABORATORIES  WOCKHARDT LTD.  VENUS REMEDIES  PLETHICO PHARMA  GLENMARK PHARMA  

Compare BIOCON LTD With:   ADCOCK INGRAM (S. Africa)  MYLAN (US)  ACTAVIS (US)  TEVA PHARMA (Israel)  



Today's Market

Sensex Ends 219 Points Lower; Energy and Auto Stocks Witness Selling(Closing)

After witnessing volatile trades during the day, Indian share markets ended their session on a negative note. Losses were largely seen in the oil & gas sector, auto sector.

Related Views on News

Biocon: US Pricing Pressure Takes Toll (Quarterly Results Update - Detailed)

Feb 2, 2018

Pricing pressure in the US and costs of the Malaysian facility hit Biocon's profits in the third quarter.

Aster DM Healthcare (IPO)

Feb 10, 2018

Should you subscribe to the IPO of Aster DM Healthcare Ltd?

Dr Reddy's: Milestone Payment Drives Sales (Quarterly Results Update - Detailed)

Feb 9, 2018

US business was hit by pricing pressure although there was growth sequentially led by new product launches.

Lupin: US market Declines Due to Higher Base Effect of FY17 (Quarterly Results Update - Detailed)

Feb 9, 2018

Price erosion in generic US drugs continues but seems to be bottoming out.

Shalby Ltd. (IPO)

Dec 2, 2017

Should you subscribe to the IPO of Shalby Ltd?

More Views on News

Most Popular

Alert: Pharma Stocks Are About to Shoot Up - And a Superb Stock for Trading(Profit Hunter)

Jun 13, 2018

The ailing pharma stocks are bouncing back to health. Read this to find out the best way to profit from them.

Will You Dump Your Client if You're Busy? Inox Wind's Auditor Just Did...(The 5 Minute Wrapup)

Jun 14, 2018

After Inox Wind, you may see more auditors resigning And the reasons can be as funny as they can get.

GST Will Not Solve Problem of High Prices of Petrol and Diesel(Vivek Kaul's Diary)

Jun 13, 2018

Though it will bring transparency in their pricing and that in itself will be a welcome move.

Should You Invest In Mirae Asset Healthcare Fund?(Outside View)

Jun 15, 2018

Mirae Asset Mutual Fund launches NFO - Mirae Asset Helathcare Fund.

This Behaviour is Injurious to Wealth Building(Sector Info)

Jun 13, 2018

Blindly following the herd can be the biggest wealth destroyer.

More

Small Investments
BIG Returns

Zero To Millions Guide 2018
Get our special report, Zero To Millions
(2018 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

BIOCON LTD SHARE PRICE


Jun 25, 2018 03:35 PM

TRACK BIOCON LTD

  • Track your investment in BIOCON LTD with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

BIOCON LTD - ABBOTT INDIA COMPARISON

COMPARE BIOCON LTD WITH

MARKET STATS